H.Res. 1245 is a resolution that acknowledges the significance of the Greenhouse Gas Reporting Program. The resolution emphasizes that this program is essential for maintaining scientific integrity, protecting public health, safeguarding the environment, and promoting economic growth in the United States. It likely calls for continued support and funding for the program to ensure its effectiveness.
Media outlets that support environmental protection have praised H.Res. 1245 for its recognition of the Greenhouse Gas Reporting Program. They highlight that the resolution underscores the importance of transparency in greenhouse gas emissions reporting, which is crucial for informed public policy and climate action. Supporters argue that it will help bolster scientific research and public awareness regarding climate change.
Critics of H.Res. 1245 have expressed concerns that the resolution may be used to justify increased regulations on businesses, potentially hindering economic growth. Some media outlets argue that the emphasis on greenhouse gas reporting might lead to excessive governmental oversight and could be seen as a move towards more stringent environmental policies that could impact job creation in certain industries.
The analysis of H.Res. 1245 reveals no direct industry overlaps between the sponsor Luz Rivas's top donor industries and the bill's focus on the Greenhouse Gas Reporting Program. While there is lobbying activity in the policy area, the disclosed contributions from Amgen Inc. ($5,000) and Grand Pharmaceutical Group Ltd. ($90,000) do not directly correlate with the environmental focus of the bill. The majority of lobbying activities are undisclosed, making it challenging to ascertain their influence. However, the absence of direct financial ties to the bill's subject matter suggests a low risk of conflict of interest. Voters should be aware that while some lobbying exists, it does not appear to directly impact the integrity of the bill.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| GRAND PHARMACEUTICAL GROUP LTD (FKA EAST OCEAN MEDICAL (HONG KONG) LIMITED) | CHECKMATE GOVERNMENT RELATIONS | $90,000 |
| ROCKY MOUNTAIN ELK FOUNDATION | DOUBLE HAUL STRATEGIES LLC | $9,000 |
| AMGEN INC. | WASHINGTON ADVOCACY GROUP | $5,000 |
| FUEL ETHANOL DISRUPTIVE BIOTECHNOLOGY RESEARCH CENTER INCORPATED | MR. AMIR GOULART SCHARIF | undisclosed |
| FUEL ETHANOL DISRUPTIVE BIOTECHNOLOGY RESEARCH CENTER INCORPATED | MR. AMIR GOULART SCHARIF | undisclosed |
| BLACKSTONE CONSTRUCTION LLC | WASHINGTON ADVOCACY GROUP | undisclosed |
| DENALI WATER SOLUTIONS | WASHINGTON ADVOCACY GROUP | undisclosed |
| NATIONAL ASSOCIATION OF PROFESSIONAL EMPLOYER ORGANIZATIONS (NAPEO) | ARENTFOX SCHIFF LLP | undisclosed |
| RROMA COUNCIL | RROMA COUNCIL | undisclosed |
| BAJO COHEN AGLIANO, P.A. ON BEHALF OF HEALTH EDGE INVESTMENT PARTNERS, LLC | BALLARD PARTNERS | undisclosed |
| ERUDIO BIO, INC. | BALLARD PARTNERS | undisclosed |
| THE LOUIS D. BRANDEIS CENTER FOR HUMAN RIGHTS UNDER LAW | THE LOUIS D. BRANDEIS CENTER FOR HUMAN RIGHTS UNDER LAW | undisclosed |
| CELLIGENCE LLC | BALLARD PARTNERS | undisclosed |
| PENN ENTERTAINMENT, INC. | BALLARD PARTNERS | undisclosed |
| COMMUNITY BANK ADVISORY SERVICES, LLC | COMMUNITY BANK ADVISORY SERVICES, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Luz Rivas, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
